Cargando…
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
The Middle East respiratory syndrome coronavirus (MERS-CoV) has spread through 27 countries and infected more than 2,200 people since its first outbreak in Saudi Arabia in 2012. The high fatality rate (35.4%) of this novel coronavirus and its persistent wide spread infectiousness in animal reservoir...
Autores principales: | Xu, Jiuyang, Jia, Wenxu, Wang, Pengfei, Zhang, Senyan, Shi, Xuanling, Wang, Xinquan, Zhang, Linqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567157/ https://www.ncbi.nlm.nih.gov/pubmed/31169078 http://dx.doi.org/10.1080/22221751.2019.1624482 |
Ejemplares similares
-
Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
por: Jia, Wenxu, et al.
Publicado: (2019) -
Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
por: Zhang, Senyan, et al.
Publicado: (2018) -
Vaccine against Middle East respiratory syndrome coronavirus
por: Shen, Xuejuan, et al.
Publicado: (2019) -
Vaccine against Middle East respiratory syndrome coronavirus
por: Zumla, Alimuddin, et al.
Publicado: (2019) -
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
por: Payne, Daniel C., et al.
Publicado: (2016)